Stockscreener 앱 받기
143.91
3.05%
-4.53
시간 외 거래:
146.00
2.09
+1.45%
전일 마감가:
$148.44
열려 있는:
$149.325
하루 거래량:
3.30M
Relative Volume:
1.98
시가총액:
$26.61B
수익:
$15.41B
순이익/손실:
$1.37B
주가수익비율:
19.19
EPS:
7.5
순현금흐름:
$2.11B
1주 성능:
+0.48%
1개월 성능:
-22.17%
6개월 성능:
-38.47%
1년 성능:
-36.67%
1일 변동 폭
$143.50
$149.32
1주일 범위
$140.64
$152.48
52주 변동 폭
$135.97
$252.88
아이큐비아 홀딩스 Stock (IQV) Company Profile
명칭
Iqvia Holdings Inc
전화
919-998-2000
주소
2400 ELLIS ROAD, DURHAM, NC
IQV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
아이큐비아 홀딩스 Stock (IQV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-02-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-12-20 | 개시 | Stephens | Overweight |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-09-04 | 개시 | RBC Capital Mkts | Outperform |
| 2024-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-15 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-02-13 | 개시 | BTIG Research | Buy |
| 2023-11-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-03-17 | 개시 | Truist | Buy |
| 2022-12-06 | 개시 | Cowen | Outperform |
| 2022-11-17 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2022-05-24 | 개시 | Guggenheim | Buy |
| 2022-04-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-16 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2020-07-07 | 개시 | Stephens | Equal-Weight |
| 2020-03-02 | 개시 | Deutsche Bank | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-12-13 | 업그레이드 | CFRA | Sell → Hold |
| 2019-11-14 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | 업그레이드 | Mizuho | Neutral → Buy |
| 2019-05-28 | 개시 | SVB Leerink | Outperform |
| 2019-01-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-10-09 | 개시 | UBS | Buy |
| 2018-10-02 | 재확인 | Robert W. Baird | Outperform |
| 2018-07-25 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | 재확인 | Stifel | Buy |
| 2018-07-03 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-03-07 | 업그레이드 | SunTrust | Hold → Buy |
| 2018-01-19 | 개시 | Evercore ISI | Outperform |
모두보기
아이큐비아 홀딩스 주식(IQV)의 최신 뉴스
(IQV) On The My Stocks Page - news.stocktradersdaily.com
Record-Breaking $102B Biopharma R&D Investment Signals Industry Recovery - Stock Titan
Bank of America Adjusts Price Target for Iqvia (IQV) to $190 | I - GuruFocus
Barclays Downgrades Iqvia (IQV) Amid Concerns Over Pharma Tariffs | IQV Stock News - GuruFocus
Truist cuts IQVIA stock price target to $216, keeps Buy rating - Investing.com Canada
IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last? - Yahoo Finance
IQVIA (IQV) Downgraded by Barclays Over Tariff Concerns - GuruFocus
Truist Adjusts IQVIA Holdings' PT to $216 From $263, Keeps Buy Rating - MarketScreener
Iqvia, Icon, Fortrea downgraded at Barclays on tariff overhang - Seeking Alpha
Truist Lowers Iqvia (IQV) Price Target Amid CRO Sector Challenges | IQV Stock News - GuruFocus
Barclays Downgrades IQVIA Holdings to Equalweight From Overweight, Adjusts PT to $170 From $235 - MarketScreener
Barclays cuts IQVIA stock rating, slashes price target to $170 By Investing.com - Investing.com South Africa
Barclays cuts IQVIA stock rating, slashes price target to $170 - Investing.com Australia
Evercore ISI Adjusts Price Target on IQVIA Holdings to $165 From $245, Maintains Outperform Rating - MarketScreener
Goldman Sachs Adjusts IQVIA Holdings Price Target to $200 From $230, Maintains Buy Rating - MarketScreener
IQVIA Holdings Inc. (IQV): Among Stocks with Buy Ratings that Hedge Funds Love - Insider Monkey
IQVIA Holdings (NYSE:IQV) Sees 13% Weekly Price Dip Amid Credit Agreement Amendment - Yahoo
Leerink Partners Adjusts IQVIA Holdings Price Target to $245 From $259, Maintains Outperform Rating - MarketScreener
Decentralized TrialsHybrid & Virtual Trials Solution - IQVIA
Earnings grew faster than the respectable 6.4% CAGR delivered to IQVIA Holdings (NYSE:IQV) shareholders over the last five years - Yahoo Finance
IQVIA Holdings Inc.'s (NYSE:IQV) Shareholders Might Be Looking For Exit - simplywall.st
Is IQVIA Holdings (NYSE:IQV) A Risky Investment? - Yahoo Finance
Truist Financial Remains a Buy on IQVIA Holdings (IQV) - The Globe and Mail
IQV stock touches 52-week low at $179.23 amid market challenges - Investing.com India
Here's Why Investors Must Hold IQV Stock in Their Portfolios Now - TradingView
What Is IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Doing? - Yahoo Finance
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
Why IQVIA Holdings Inc. (IQV) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey
Boasting A 23% Return On Equity, Is IQVIA Holdings Inc. (NYSE:IQV) A Top Quality Stock? - Yahoo
Long Term Trading Analysis for (IQV) - news.stocktradersdaily.com
IQVIA Holdings (IQV) Fell on Lowered Guidance - MSN
3 Reasons IQV is Risky and 1 Stock to Buy Instead - Yahoo Finance
IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 100% Above Its Share Price - Yahoo Finance
Sequoia Financial Advisors LLC Grows Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Mizuho Adjusts Price Target on IQVIA Holdings to $242 From $247, Maintains Outperform Rating - Marketscreener.com
Is IQVIA Holdings Stock Underperforming the Dow? - Nasdaq
Jones Financial Companies Lllp Buys 441 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
Is IQVIA Holdings Stock Underperforming The Dow? - Barchart.com
Victory Capital Management Inc. Sells 9,038 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
IQVIA (NYSE:IQV) Downgraded to “Hold” Rating by StockNews.com - Defense World
Argus Adjusts IQVIA Holdings Price Target to $245 From $260, Maintains Buy Rating -March 11, 2025 at 09:47 am EDT - Marketscreener.com
SBI Securities Co. Ltd. Acquires New Holdings in IQVIA Holdings Inc. (NYSE:IQV) - Defense World
IQVIA Holdings (NYSE:IQV) Secures Loan Refinancing To Reduce Interest Rate By 0.25% Points - Yahoo Finance
(IQV) Investment Report - news.stocktradersdaily.com
IQVIA Holdings Refinances Debt, Lowers Interest Rate By Investing.com - Investing.com South Africa
IQVIA Holdings Refinances Debt, Lowers Interest Rate - Investing.com
IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services - StockTitan
StockNews.com Upgrades IQVIA (NYSE:IQV) to "Buy" - MarketBeat
아이큐비아 홀딩스 (IQV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아이큐비아 홀딩스 주식 (IQV) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DANHAKL JOHN G | Director |
Dec 03 '24 |
Buy |
200.58 |
1,275 |
255,740 |
1,275 |
| Sherbet Eric | See Remarks |
Aug 27 '24 |
Sale |
246.33 |
1,300 |
320,229 |
19,536 |
0.21%
2.26%
자본화:
|
볼륨(24시간):